Scientists at the Institute of Molecular Biology and Biotechnology (IMBB-FORTH) and the University of Crete, together with ...
Optibumin® 25 in 100 mL bags: The first recombinant 25% human serum albumin solution designed for closed-system biomanufacturing. Recombinant alternative to plasma-derived HSA enables safer, scalable, ...
Albumin is the most common protein in the blood, a vital molecule produced by the liver that helps maintain fluid balance and ...
EPO grants Sonnet EU Patent No. EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion proteins, expanding global IP protection. Sonnet BioTherapeutics Holdings, Inc. announced that the ...